Fantegrossi, W E; Ko, M C H; Woods, J H et al. (2005) Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Pharmacol Biochem Behav 80:341-9
|
Shilling, P D; Melendez, G; Priebe, K et al. (2004) Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharmacology (Berl) 175:353-9
|
Wang, Rui; Boules, Mona; Tiner, William et al. (2004) Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro. Brain Res 1025:21-8
|
Shilling, P D; Richelson, E; Feifel, D (2003) The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition. Behav Brain Res 143:7-14
|
Fredrickson, Paul; Boules, Mona; Yerbury, Sally et al. (2003) Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization. Brain Res 979:245-8
|
Fredrickson, Paul; Boules, Mona; Yerbury, Sally et al. (2003) Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Eur J Pharmacol 458:111-8
|
Hong, Feng; Zaidi, Javid; Cusack, Bernadette et al. (2002) Synthesis and biological studies of novel neurotensin(8-13) mimetics. Bioorg Med Chem 10:3849-58
|
Boules, M; McMahon, B; Warrington, L et al. (2001) Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties. Brain Res 919:1-11
|
Boules, M; Warrington, L; Fauq, A et al. (2001) A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. Eur J Pharmacol 426:73-6
|
Boules, M; Warrington, L; Fauq, A et al. (2001) Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. Eur J Pharmacol 428:227-33
|
Showing the most recent 10 out of 85 publications